| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
4 companies
Rock Springs Capital Management LP is a 10% Owner at Xilio Therapeutics, Inc. with holdings across 4 companies. Recent SEC Form 4 filings include 5 buys and 0 sells.
Estimated insider holdings value: $34.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 26, 2021 | XLO Xilio Therapeutics, Inc. | 10% Owner | Buy | 500,000 | $16.00 | $8,000,000.00 | +66.1% | -12.5% | -86.4% | |
| Nov 3, 2020 | AVIR Atea Pharmaceuticals, Inc. | 10% Owner | Buy | 250,000 | $24.00 | $6,000,000.00 | +14.8% | - | - | |
| Mar 16, 2020 | ELVN Enliven Therapeutics, Inc. | 10% Owner | Buy | 250,000 | $16.00 | $4,000,000.00 | +91.4% | - | - | |
| Apr 2, 2018 | 10% Owner | Buy | 250,000 | $16.00 | $4,000,000.00 | +63.2% | - | - |